Abstract: A storage and transport system for sodium hypochlorite pentahydrate (solid bleach) is provided. The system includes a container configured to receive and store crystalline solid bleach that includes of at least forty percent sodium hypochlorite, and to retain decomposition components from crystalline solid bleach stored in the container. The container includes a containment wall at least partially surrounding an interior containment space configured to receive solid bleach therein. A passage extends from exterior the container to the interior containment space. The passage is configured for solid bleach to pass therethrough. A liner is located at an interior surface of the containment wall. The liner is substantially non-reactive with solid bleach and, without leakage, capable of retaining within the containment space: (a) solid bleach, (b) decomposition components of solid bleach and (c) liquid bleach formed when dissolving water is added to solid bleach within the containment space.

Abstract: Disclosed herein are processes for producing highly concentrated bleach slurries containing a mixture of crystals of solid sodium hypochlorite pentahydrate in a liquid phase saturated in sodium hypochlorite and containing sodium hydroxide or other alkaline stabilizers. Bleach slurries and compositions exhibiting enhanced stability are also disclosed.

Abstract: Disclosed herein are processes for producing highly concentrated bleach slurries containing a mixture of crystals of solid sodium hypochlorite pentahydrate in a liquid phase saturated in sodium hypochlorite and containing sodium hydroxide or other alkaline stabilizers. Bleach slurries and compositions exhibiting enhanced stability are also disclosed.

Abstract: Pharmaceutical compositions and methods for delivering a polypeptide to the central nervous system of a mammal via intranasal administration are provided. The polypeptide can be a catalytically active protein or an antibody, antibody fragment or antibody fragment fusion protein. The polypeptides are formulated with one or more specific agents.

Abstract: The present invention relates to non-aqueous high concentration reduced viscosity suspension formulations of antibodies and methods of making and using them.

Abstract: Pharmaceutical compositions and methods for delivering a polypeptide to the central nervous system of a mammal via intranasal administration are provided. The polypeptide can be a catalytically active protein or an antibody, antibody fragment or antibody fragment fusion protein. The polypeptides are formulated with one or more specific agents.

Abstract: The present invention relates to non-aqueous high concentration reduced viscosity suspension formulations of antibodies and methods of making and using them.

Abstract: The present invention relates to non-aqueous high concentration reduced viscosity suspension formulations and methods of making and using them.

Abstract: Pharmaceutical compositions and methods for delivering a polypeptide to the central nervous system of a mammal via intranasal administration are provided. The polypeptide can be a catalytically active protein or an antibody, antibody fragment or antibody fragment fusion protein. The polypeptides are formulated with one or more specific agents.

Abstract: A modified bone morphogenetic protein (BMP, also referred to as bone morphogenic protein) composition is described. The bone morphogenetic protein, in one embodiment, is BMP-7 which is chemically modified with a hydrophilic polymer, such as poly(ethylene glycol).

Abstract: A method for delivering a polypeptide to the central nervous system of a mammal is provided. The method involves attaching the polypeptide to an antibody or an antibody fragment and administering the fusion polypeptide intranasally, for delivery to the central nervous system. Methods of treatment are also provided, where a therapeutically effective amount of the composition is delivered to the nasal cavity of a mammal.

Abstract: A suspension formulation for therapeutic use includes a non-aqueous, single-phase vehicle exhibiting viscous fluid characteristics and a particle formulation comprising an erythropoietin receptor agonist dispersed in the vehicle.

Abstract: A switchgear cabinet includes a plurality of securing apparatuses that are mounted on a vertical flange of the switchgear cabinet, with the securing apparatuses each being formed with a locking hole that is engageable by a pin of a locking mechanism on a door member. Each securing apparatus includes an anchor plate connected with a first bracket and a second bracket, with the first and second brackets being mounted on the flange of the switchgear cabinet. The locking hole is formed in the anchor plate, and the anchor plate is substantially planar and free of bends. The anchor plate further is generally U-shaped and is configured to extend generally around at least a portion of the flange.

Abstract: A switchgear cabinet includes a plurality of securing apparatuses that are mounted on a vertical flange of the switchgear cabinet, with the securing apparatuses each being formed with a locking hole that is engageable by a pin of a locking mechanism on a door member. Each securing apparatus includes an anchor plate connected with a first bracket and a second bracket, with the first and second brackets being mounted on the flange of the switchgear cabinet. The locking hole is formed in the anchor plate, and the anchor plate is substantially planar and free of bends. The anchor plate further is generally U-shaped and is configured to extend generally around at least a portion of the flange.

Abstract: An automatically operating interlock prevents connection of an electrical device within a cabinet unless the cabinet door is closed. The interlock is particularly useful for circuit breakers contained within arc-resistant cabinets. The interlock includes a spring-biased locking plate reciprocating between a locked position wherein the locking plate resists movement of the levering-in locking plate, and an unlocked position wherein the locking plate permits movement of the levering-in locking plate. The locking plate is spring-biased towards its locked position, and is pushed from its locked position to its unlocked position when the cabinet door is closed. Access to the hex drive of the levering-in rod is thereby resisted when the cabinet door is open.